This new B. burgdorferi IgG/IgM VlsE-OspC EIA test, when used in conjunction with the other FDA cleared GSD Lyme EIA tests, can be used in the CDC recommended modified two-tiered testing (MTTT) algorithm.
The Carlsbad, Calif, Quidel facility aims to reach a run rate of 600 million QuickVue tests per year by the end of 2021.
EuroImmun’s CE-marked Antigen ELISA is able to be applied in semi quantitative automatable detection of the SARS-CoV-2 nucleocapsid protein on a large scale.
The microplate reader can be retrofitted for point-of-care clinical testing at urgent care facilities, hospitals, or physicians’ offices.
The PKamp Respiratory SARS-CoV-2 RT-PCR Panel enables differential diagnosis between covid-19, flu, and RSV infections.
SeptiCyte Rapid distinguishes sepsis from non-infectious systemic inflammation in patients suspected of sepsis and provides actionable results in about 1 hour.